Resources

Publications

12/04/2023
- Oncology
Real-World Evaluation of Racial and Socioeconomic Disparities in Patients With NSCLC Treated With Immunotherapy
IASLC NACLC 2023
12/01/2023
- Oncology
Radiogenomics For EGFR Mutation Status Prediction in CT Images: Impact Of Model Design on Performance and Prospective Generalizability
RSNA 2023
11/19/2023
- Genomic Sequencing
Performance of Copy Number Variant Detection From Short-Read Whole Genome Sequencing For Clinical Gene-Panel Applications
AMP 2023
11/06/2023
- Genomic Sequencing
Evaluating the Performance of Copy Number Variant Detection Tools in Clinical Applications: A Comparative Benchmark for Short-Read Whole Genome Sequencing
ASHG 2023
11/06/2023
- Genomic Sequencing
Racial Differences in UGT1A1 Allele Frequencies and Its Potential Impact in Pharmacogenetic Testing for Cancer Chemotherapy Drugs
ASHG 2023
11/04/2023
- Oncology
Genomic Characterization of Chondrosarcoma: A Rare Sarcoma With Clinical Responses to Immune Checkpoint Inhibition
CTOS 2023
11/03/2023
- Oncology
EVEREST-1: A seamless phase 1/2 study of CEA logic-gated Tmod CAR T-cell therapy (A2B530) in patients with solid tumors associated with CEA expression also exhibiting HLA loss of heterozygosity (LOH)
SITC 2023
11/03/2023
- Oncology
BASECAMP-1: A master prescreening study to identify patients with high-risk or metastatic solid tumors with HLA loss of heterozygosity (LOH) in preparation for Tmod CAR T-cell therapy trials
SITC 2023
11/03/2023
- Oncology
Association of a novel circulating tumor fraction DNA biomarker of treatment response monitoring and clinical outcomes in a real-world, diverse pan-cancer cohort treated with immunotherapy
SITC 2023
11/03/2023
- Oncology
Multimodal real world data reveals immunogenomic drivers of acquired and primary resistance to immune checkpoint blockade
SITC 2023

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40